NCT07118423

Brief Summary

This study is a multicenter intervention evaluating the effectiveness and safety of resistance training in institutionalized centenarians. The aim of the study is to analyze the effects of 12 weeks of resistance training on frailty, muscle power, physical function, strength, functional independence, physical activity, cardiovascular health, cognitive function, and quality of life in adults aged 100 and over living in nursing homes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
5.3 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 12, 2025

Completed
Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

1.2 years

First QC Date

July 14, 2025

Last Update Submit

August 8, 2025

Conditions

Outcome Measures

Primary Outcomes (24)

  • Frailty using Fried's Frailty Criteria

    Fried's frailty phenotype is based on five criteria (habitual gait speed, handgrip strength , involuntary weight loss, exhaustion and low physical activity). The score ranges from 0 to 5, where each criterion met counts as one point. A score of 0 indicates best status, while a score of 5 indicates worst status.

    T0 (baseline) and T1 (post 12 weeks)

  • Frailty using Frailty Trait Scale - Short Form

    Frailty Trait Scale - Short Form evaluates 5 domains, including body mass index, physical activity, static balance, habitual gait speed and handgrip strength. The score ranges from 0 to 50, where each criterion met counts as one point. A score of 0 indicates best status, while a score of 50 indicates worst status.

    T0 (baseline) and T1 (post 12 weeks)

  • Muscle power

    Muscle power assessed in 30-s sit-to-stand test.

    T0 (baseline) and T1 (post 12 weeks)

  • Physical function based on the Short Physical Performance Battery

    The Short Physical Performance Battery is based on the ability to stand with the feet together in the side-by-side, semi-tandem, and tandem positions, time to walk 4 meters, and time to rise from a chair and return to the seated position 5 times. The score ranges from 0 to 12 points. Higher scores indicate better physical function, while lower scores reflect poorer physical function.

    T0 (baseline) and T1 (post 12 weeks)

  • Physical function using Physical Performance Mobility Examination.

    The Physical Performance Mobility Examination includes six mobility tasks integral to daily life: bed mobility, transfer skills, multiple stands from chair, standing balance, step-up, and ambulation. The score ranges from 0 to 12 points. Higher scores indicate better physical function, while lower scores reflect poorer physical function.

    T0 (baseline) and T1 (post 12 weeks)

  • Physical function based on the gait speed in 6 meters.

    Gait speed is measured in meters per second (m/s). Higher values indicate better mobility.

    T0 (baseline) and T1 (post 12 weeks)

  • Physical function using the Time Up and Go test.

    The Timed Up and Go test measures the time it takes participants to stand up, walk 3 meters, turn around, and sit back down. Shorter times reflect better mobility

    T0 (baseline) and T1 (post 12 weeks)

  • Cognitive function using Mini Mental State Examination.

    Mini Mental State Examination questionnaire incorporates 11 items that measure attention and orientation, memory, registration, recall, calculation, language, and ability to draw a complex polygon, and results in scores ranging from 1 (lowest cognitive function) to 30 (highest cognitive function) points.

    T0 (baseline) and T1 (post 12 weeks)

  • Cognitive function using the animal naming test within 1 minute.

    In the animal naming test, participants are asked to name as many animals as possible in 60 seconds. The higher number of correctly named reflects better cognitive function.

    T0 (baseline) and T1 (post 12 weeks)

  • Cognitive function using the clock drawing test.

    The score in the clock drawing test ranges from 0 to 10. This score evalutes visuospatial skills, executive functions, and the ability to follow instructions. Higher scores indicate better cognitive function.

    T0 (baseline) and T1 (post 12 weeks)

  • Quality of life using EuroQoL-5 Dimension questionnaire.

    EuroQoL-5D Index ranges from a value of 1 (best state of health) to 0 (death). Although there are negative values for the index, corresponding to those states of health that are valued as worse than death.

    T0 (baseline) and T1 (post 12 weeks)

  • Quality of life using Visual Analog Scale.

    Visual Analog Scale evaluates self-reported quality of life on a vertical scale ranging from 0 (worst health) to 100 (best health). This score provides a subjective measure of the patient's perception of their current health status.

    T0 (baseline) and T1 (post 12 weeks)

  • Isometric muscle strength

    Maximum voluntary isometric strength in handgrip, knee extension, elbow flexion and should abduction, measured using a dynamometer.

    T0 (baseline) and T1 (post 12 weeks)

  • Disability

    The Barthel index is a 10-item questionnaire that provides information about the autonomy to cook food, wash, dress, groom, perform bowel movements and urination, go to the toilet, move from the bed to the chair, walk and climb stair. The total score ranges from 0 to 100, with higher scores indicating greater independence (best), and lower scores indicating higher levels of dependence in basic daily activities.

    T0 (baseline) and T1 (post 12 weeks)

  • Accelerometer-based physical activity

    Measurement of physical activity levels (i.e., time spent in light-intensity and moderate-to-vigorous intensity) by accelerometer 24 hours a day for seven consecutive days using a GENEActiv device worn on the non-dominant wrist.

    T0 (baseline) and T1 (post 12 weeks)

  • Falls

    The number of falls in the last year was registered.

    T0 (baseline) and T1 (post 12 weeks)

  • Heart rate variability indices from electrocardiogram (ECG)

    Heart rate variability indices were derived from 10-minute resting recordings using a 12-lead Holter ECG. Both linear indices (time and frequency domains) and non-linear indices (detrended fluctuation ) were calculated from the ECG recording.

    T0 (baseline) and T1 (post 12 weeks)

  • Blood pressure

    Blood pressure is measured in millimeters of mercury (mmHg), including systolic, diastolic, and mean arterial pressure (calculated as diastolic pressure plus one-third of the difference between systolic and diastolic pressures).

    T0 (baseline) and T1 (post 12 weeks)

  • Ankle-brachial index relate to blood pressure

    The ankle-brachial index (ABI) is calculated by measuring systolic pressure in both ankles and both arms. The highest systolic pressure from the arms is used as a reference. The highest systolic pressure from each ankle is divided by this reference to obtain an ABI for each leg. The final ABI value is the lower of the two leg measurements.

    T0 (baseline) and T1 (post 12 weeks)

  • Albumin

    Albumin concentration is measured in blood samples.

    T0 (baseline) and T1 (post 12 weeks)

  • C-reactive protein

    C-reactive protein concentration is measured in blood samples.

    T0 (baseline) and T1 (post 12 weeks)

  • inflammatory cytokines

    Inflammatory cytokines (IL-6 and IL-1β) are measured in blood samples.

    T0 (baseline) and T1 (post 12 weeks)

  • Circulating microRNA levels

    MicroRNAs associated with frailty (miR-194-5p, miR-125b-5p) are measured in blood samples.

    T0 (baseline) and T1 (post 12 weeks)

  • Gene expressions of aging (ABLIM1, CCR7, LEF1, EGR1)

    Gene expressions of aging (ABLIM1, CCR7, LEF1, EGR1) are measured in blood samples.

    T0 (baseline) and T1 (post 12 weeks)

Secondary Outcomes (1)

  • Resilience

    Only baseline (T0)

Study Arms (2)

Exercise group

EXPERIMENTAL

The exercise group performed twice per week, nonconsecutive, resistance training over 12 weeks. Exercise sessions consisted of 1-3 sets of the 8-exercise routine at 50-70% of the estimated one-repetition maximum.

Other: Exercise

Control group

NO INTERVENTION

The control group received the usual care in nursing homes.

Interventions

The intervention group performed twice per week, nonconsecutive, resistance training over 12 weeks. The sessions consisted of 1-3 sets of eight exercises at 50-70% of the estimated one-repetition maximum.

Exercise group

Eligibility Criteria

Age100 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Women and men aged 100 years and over living in geriatric nursing homes.

You may not qualify if:

  • Participants were excluded if they were bedridden, going through an acute disease or presented any clinical condition contraindicating physical exercise as outlined in the American College of Sports Medicine's Guidelines.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Zaragoza

Zaragoza, Zaragoza, Spain

Location

MeSH Terms

Conditions

FrailtyMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Nuria Garatachea, PhD

    Universidad de Zaragoza

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

July 14, 2025

First Posted

August 12, 2025

Study Start

January 8, 2019

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

August 12, 2025

Record last verified: 2025-08

Locations